People with strabismus, myopia, amblyopia, and other common eye conditions are 40% more likely to develop attention-deficit/hyperactivity disorder (ADHD) than those ...

Drug development for neurodegenerative diseases is struggling with one of its most intractable barriers: the slow, variable, and subjective nature of clinical endpoints Traditional assessment scales, ...

Researchers have developed a novel synthetic protein to treat macular degeneration and other incurable eye diseases that lead to blindness in millions of people. It is the first drug of its kind and ...

Using piezoelectricity, an engineering team developed wearable sensors to examine eye movement to assess brain disorders or damage to the brain. A University of Houston engineering team has developed ...

Temporomandibular joint disorders (TMD) might cause the jaw to press on nerves that affect eye movement and contribute to vision issues, such as astigmatism, nearsightedness, and farsightedness. TMD ...

For some degenerative vision disorders, the therapies available don’t restore sight, they mainly slow its decline. To realize this benefit, a patient must receive an eye injection as frequently as ...

Combining artificial intelligence and genetics has allowed researchers to study the part of the eye that gives us sharp central vision in amazing detail for the first time. Subscribe to our newsletter ...

The Ocular Neurobiology laboratory at the Institute for Neurosciences, a joint center of Miguel Hernández University (UMH) in Elche and the Spanish National Research Council (CSIC), is participating ...

Semaglutide showed no significant association with increased risk of eye disorders or diabetic retinopathy in the meta-analysis. A potential link between semaglutide and increased risk of NAION was ...

Adds shares in paragraph 1, details of trial in paragraphs 2-3 July 24 (Reuters) - Kodiak Sciences Inc KOD.O decided to discontinue development of its experimental drug to treat a type of eye disorder ...